Novavax Stock Discussion

$Novavax (NVAX.US)$ just short it, rigged market for everyone

Over 14.09 a gap test  becomes more likely. Here are the levels to watch.
Larger Image: tradingview.com...
$Novavax (NVAX.US)$  

$Novavax (NVAX.US)$ said Friday that doses of its updated vaccine to prevent COVID-19 in people at least 12 years old are now available in the US.
The company said its 2024-2025 formula COVID-19 vaccine is in stock at major pharmacy retailers nationwide.

Great presentation by $Novavax (NVAX.US)$ at Baird 2024 Global Healthcare Conference, couple of encouraging points:
* Partnering with Sanofi and Serum Institute providing significant revenue opportunities in the form of royalties and markey expansion
* Expense reduction looks big, so I would expect at least break even, or profit making. Looking forward to FY results
* Pipeline broadening - pneumococcal, RSV and H5N1 mentioned. Promosing data showing superiority for pneumococcal expected

$Novavax (NVAX.US)$ 🧐🧐🧐 doubt

$Novavax (NVAX.US)$ it's crazy how this went up and dropped so much in a few hours.

Nice move up today into AH. Here are the levels to watch. Stopped at the 12.80 resistance so far. Support 12.22.
Larger Image: tradingview.com...
$Novavax (NVAX.US)$  

$Novavax (NVAX.US)$
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
Novavax has received Emergency Use Authorization (EUA) from the FDA for its 2024-2025 Formula COVID-19 Vaccine(NVX-CoV2705) for individuals aged 12 and older. The vaccine is included in the CDC's recommendations and will be available in pre-filled syringes at thousands of locations across the U.S. Novavax's vaccine is the only protein-based option available in the U.S. for COVID...